Back to Search
Start Over
Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling
- Source :
- Journal of Medicinal Chemistry. 61:4528-4560
- Publication Year :
- 2018
- Publisher :
- American Chemical Society (ACS), 2018.
-
Abstract
- Transglutaminase 2 (TGase 2)-catalyzed transamidation represents an important post-translational mechanism for protein modification with implications in physiological and pathophysiological conditions, including fibrotic and neoplastic processes. Consequently, this enzyme is considered a promising target for the diagnosis of and therapy for these diseases. In this study, we report on the synthesis and kinetic characterization of Ne-acryloyllysine piperazides as irreversible inhibitors of TGase 2. Systematic structural modifications on 54 new compounds were performed with a major focus on fluorine-bearing substituents due to the potential of such compounds to serve as radiotracer candidates for positron emission tomography. The determined inhibitory activities ranged from 100 to 10 000 M–1 s–1, which resulted in comprehensive structure–activity relationships. Structure–activity correlations using various substituent parameters accompanied by covalent docking studies provide an advanced understanding of the...
- Subjects :
- 0301 basic medicine
chemistry.chemical_classification
biology
Tissue transglutaminase
Substituent
03 medical and health sciences
chemistry.chemical_compound
030104 developmental biology
Enzyme
chemistry
Biochemistry
Pharmacokinetics
Docking (molecular)
Covalent bond
Drug Discovery
Posttranslational modification
biology.protein
Molecular Medicine
Neoplastic Processes
Subjects
Details
- ISSN :
- 15204804 and 00222623
- Volume :
- 61
- Database :
- OpenAIRE
- Journal :
- Journal of Medicinal Chemistry
- Accession number :
- edsair.doi...........1d8994b8d9976513a76ed3052cb5f733
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.8b00286